Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer
Open accessThe DOI matches its Crossref record; 278 of the 284 references it cites were found in a registry or an index.
Abstract
Colorectal cancer (CRC) is one of the most common aggressive carcinoma types worldwide, characterized by unfavorable curative effect and poor prognosis. Epidemiological data re-vealed that CRC risk is increased in patients with metabolic syndrome (MetS) and its serum components (e.g., hyperglycemia). High glycemic index diets, which chronically raise post-prandial blood glucose, may at least in part increase colon cancer risk via the insulin/insulin-like growth factor 1 (IGF-1) signaling pathway. However, the underlying mechanisms linking IGF-1 and MetS are still poorly understood. Hyperactivated glucose uptake and aerobic glycolysis (the Warburg effect) are considered as a one of six hallmarks of cancer, including CRC. However, the role of insulin/IGF-1 signaling during the acquisition of the Warburg metabolic phenotypes by CRC cells is still poorly understood. It most likely results from the interaction of multiple processes, directly or indirectly regulated by IGF-1, such as activation of PI3K/Akt/mTORC, and Raf/MAPK signaling pathways, activation of glucose transporters (e.g., GLUT1), activation of key glycolytic enzymes (e.g., LDHA, LDH5, HK II, and PFKFB3), aberrant expression of the oncogenes (e.g., MYC, and KRAS) and/or overexpression of signaling proteins (e.g., HIF-1, TGF-β1, PI3K, ERK, Akt, and mTOR). This review describes the role of IGF-1 in glucose metabolism in physiology and colorectal carcinogenesis, including the role of the insulin/IGF system in the Warburg effect. Furthermore, current therapeutic strategies aimed at repairing impaired glucose metabolism in CRC are indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Schematic illustration of the insulin/IGF-1 system involved in the development and progression of colorectal cancer (CRC) through direct (mitotic effects) and indirect (aerobic glycolysis) activity. [↑,↓-increase (up-regulation)/decrease (down-regulation) expression/level; AMPK-adenosine monophosphate (AMP)-activated protein kinase; CRNDE-colorectal neoplasia differentially expressed gene; GLUT-glucose transporter; GH-R-growth hormone receptor; GRP78-glucose-regulated protein 78; HIF-1α, -β-hypoxia-inducible transcription factor-1α, -β; HK II-hexokinase II; IGF-1-insulin-like growth factor 1; IGFBP-1;-2-IGF binding proteins 1,-2; JAK/STAT3-Janus kinase/signal transducer and activator of transcription; KLK10-kallikrein-related peptidase; LDHA, -5-lactate dehydrogenase A, -5; mKRAS-mutant KRAS gene; mMYC-mutant MYC gene; mTP53-mutant tumor protein 53 gene; PI3K/Akt/mTOR-phosphatidylinositol 3 kinase/Akt/mammalian target of rapamycin complex; WAT-white adipose tissue].](https://figures.cochat.ai/paper-figures/f88b765def11457a838eb19e9a83d462/insulin-like-growth-factor-1-igf-1-signaling-in-glucose-metabolism-in-colorectal-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IGF1 and IGF2 have substantial effects on cell proliferation and differentiation and are effective inhibitors of apoptosis [174].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [174]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Zaafar, D. K., Zaitone, S. A., & Moustafa, Y. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100562 · Cited by 74
RetractedWu, X., Wang, L., Yang, D., Qu, M., Yang, Y., Guo, F. Y., Han, L., & Xue, J. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26399 · Cited by 51
RetractedSung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
The Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150 · cited 2×
“Although it is acknowledged that glycolysis occurs in CRC, the mechanism driving it remains largely unknown [33,40,42].”
BackgroundmTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941 · cited 1×
“It is worth noting that mTOR signaling plays an important role in mitochondrial metabolism and is also a major downstream target of the 5′ adenosine monophosphate (AMP)-activated protein kinase (AMPK) signaling [66].”
BackgroundInsulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
DAUGHADAY, W. H., & ROTWEIN, P. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-1-68 · Cited by 1,725
Cited by
Items 201–255 of 255
Hong, J. Y., Jeon, W., Kim, H., Yeo, C., Kim, H., Lee, Y. J., & Ha, I. (2025) · Biomedicines · doi:10.3390/biomedicines13010192
包, 杨. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.152562
Egba, S. I., & Chigbo, D. C. (2025) · Archives of Cancer Science and Therapy · doi:10.29328/journal.acst.1001047 · Cited by 2
Ge, Y., Huang, D., Wu, Y., Huang, W., Xu, R., Gao, L., Guo, J., & Cheng, Z. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101635
Genetic Signatures Upon Transition from Colorectal Polyps to colon Cancer
Radak, M., Ravand, F. K., Ghamari, N., & Fallahi, H. (2025) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-025-00060-1
Wang, Y., Ndandala, C. B., Fachri, M. F., Shija, V. M., Li, P., & Chen, H. (2025) · Fishes · doi:10.3390/fishes10070315 · Cited by 1
Lisieska-Żołnierczyk, S., Gajęcka, M., Zielonka, Ł., Przybyłowicz, K. E., & Gajęcki, M. T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146967 · Cited by 1
zhu, G., Sun, Y., Lian, D., Amin, B., Xu, G., Wang, J., Zhang, N., & Wang, D. (2025) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2025.103170
Tahiruddin, T., Indriastuti, D., Syahrul, S., Irwan, A. M., & Pranata, S. (2025) · Nurse Media Journal of Nursing · doi:10.14710/nmjn.v15i1.58052
Yeom, H., & Kim, Y.-J. (2025) · Journal of Health Informatics and Statistics · doi:10.21032/jhis.2025.50.3.240
Liu, Y., Wei, K., Xu, Y., & Li, D. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1633508 · Cited by 1
Hendrawan, S., Lheman, J., Marcelina, O., Tantoso, L., Baer, H. U., & Gunawan, S. (2025) · World Academy of Sciences Journal · doi:10.3892/wasj.2025.404
Minghui, J. I. N., & Lü, L. (2025) · Research Square · doi:10.21203/rs.3.rs-7868211/v1
Rachmayanti, D. A., Rejeki, P. S., Argarini, R., Novida, H., Soenarti, S., Halim, S., Permataputri, C. D. A., & Purnomo, S. P. (2025) · Diseases · doi:10.3390/diseases13120390
Li, J., Chen, J., Liu, H., Yan, S., Wang, Y., Xing, M., & Ding, S. (2024) · Figshare · doi:10.6084/m9.figshare.26684754
Li, J., Chen, J., Liu, H., Yan, S., Wang, Y., Xing, M., & Ding, S. (2024) · Figshare · doi:10.6084/m9.figshare.26684763
Li, J., Chen, J., Liu, H., Yan, S., Wang, Y., Xing, M., & Ding, S. (2024) · Figshare · doi:10.6084/m9.figshare.26684751
Li, J., Chen, J., Liu, H., Yan, S., Wang, Y., Xing, M., & Ding, S. (2024) · Figshare · doi:10.6084/m9.figshare.26684757
Wang, Z., Yu, D., Osuagwu, U. L., Pickering, K., Baker, J., Cutfield, R. G., Cai, Y., Orr‐Walker, B., Sundborn, G., Qu, B., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753413
Li, J., Chen, J., Liu, H., Yan, S., Wang, Y., Xing, M., & Ding, S. (2024) · Figshare · doi:10.6084/m9.figshare.26684760
Li, J., Chen, J., Liu, H., Yan, S., Wang, Y., Xing, M., & Ding, S. (2024) · Figshare · doi:10.6084/m9.figshare.26684766
Li, J., Chen, J., Liu, H., Yan, S., Wang, Y., Xing, M., & Ding, S. (2024) · Figshare · doi:10.6084/m9.figshare.26684748
Wang, L., Lin, Y., Liao, Y., & Shen, J. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1569824
Bracht, P., & Chiappa, A. C. (2025) · Springer eBooks · doi:10.1007/978-3-662-68881-6_18
Zhu, X., Wang, L., Hao, L., Zhang, J., Zhao, S., Zhao, C., Wang, D., & Ding, Y. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-02074-z
Chen, Q., Tang, W., Jiang, H., Li, Y., Li, Y., Chen, J., & Zhang, L. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108421
Zhang, X., Zhang, T., Wu, C., Gao, Y., Zhang, S., Li, Z., Zhong, L., Xia, C., Yang, L., Dong, F., et al. (2026) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2026020
Circulating IGF-1 levels and 27 digestive diseases: 461,401 UK biobank prospective analysis
Yang, W., Gao, J., Bao, Z., Zuo, S., Chen, Y., & Ji, R. (2026) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2026.101683
Dholaniya, P. S., Islam, H., Alvi, S. B., Mergaye, M., Kanisicak, O., & Khan, M. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-41631-y
Fouad, Y. M., Pan, Z., Mostafa, A. M., & Eslam, M. (2026) · World Journal of Meta-Analysis · doi:10.13105/wjma.v14.i1.113789 · Cited by 1
Zhao, Q., Wu, H. I., Xie, D., Shi, M., Niu, B., & Yang, L. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-03044-8
Nath, D., Ditchfield, C., Price, J. M. J., Sivakumar, S., Jones, S. W., & Acharjee, A. (2026) · Cancer Medicine · doi:10.1002/cam4.71775
Li, Z., Pei, H., Nie, Y., Fu, Z., Long, Y., Yang, J., Fu, Y., Min, F., Cui, H., Wang, N., et al. (2026) · Phytotherapy Research · doi:10.1002/ptr.70335
Gerashchenko, G. V., & Tukalo, M. A. (2026) · Biopolymers and Cell · doi:10.7124/bc.000b31
Mireles, J. A. G. (2026) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.19808398 · Cited by 1
Qur’ani, H., Nisa, N. K., Pratama, P., Kasasiah, A., & Malau, J. (2026) · Journal of Pharmaceutical And Sciences · doi:10.36490/journal-jps.com.v9i2.1320
Njoga, U. J., Njoga, E. O., Ochiogu, I. S., Ihedioha, J. I., & Oguttu, J. W. (2026) · Veterinary Sciences · doi:10.3390/vetsci13060535
Yao, Z.-Y., Ma, L.-J., Han, Z., & Ji, G.-J. (2026) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v18.i6.119114
Li, H., Shen, L., Zeng, Z., Xiao, Y., Feng, D., Peng, L., Xiang, L., Luo, Y., Wang, Y., & Cai, H. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1793362
Lei, D., Wu, J.-H., Zeng, X.-H., Xu, R., Zheng, S.-S., Zhu, X.-J., & Jian-a, Y. (2026) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2026.05.024
Uti, D. E., & Alum, E. U. (2026) · Obesity Medicine · doi:10.1016/j.obmed.2026.100725
Ding, Y., Wang, J., Wang, N., Zhu, J., Wang, X., & 段培蓓 (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1848724
Wei, Y., Gong, Y., Gong, J., Zeng, H. M., Zhong, Z., Xiong, Y., & Li, X. (2026) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2026.2701996
Jawzali, J. I. (2026) · Baghdad Journal of Biochemistry and Applied Biological Sciences · doi:10.47419/bjbabs.v7i3.487
Zhang, Y., & Liu, L. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154360
Correlation between IGF-2 and IGF-1 levels in type 1 diabetic Iraqi patients
Eltayef, E. M., Gharab, K. M. K., Ghannawi, L. A., Atta, S. E., & Salman, I. N. (2026) · Diabetes Mellitus · doi:10.14341/dm13326
Manfredelli, D., Torcoli, C., Lilli, C., Bellucci, C., Talesa, V. N., Mancuso, F., Baroni, T., & Antognelli, C. (2026) · Biology · doi:10.3390/biology15161342
Acromegaly and colorectal cancer risk: emerging roles of the gut microbiota
Grifoni, G. F. A., Favero, V., Cozzi, R. C., & Chiodini, I. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1820034
eGDR and gastrointestinal cancer mortality in the UK Biobank: a prospective cohort study
Yang, C., Plum, P. S., Ebert, T., Köppe, J., Gockel, I., & Thieme, R. (2026) · BMC Cancer · doi:10.1186/s12885-026-16931-1
Insulin-like growth factor receptor signaling in physiology and disease
Dilawar, M., Malik, A., Liao, J., Shen, P., Huang, Z., Zhang, P., Wang, J., Zhang, N., Nisar, M. F., & Chen, G. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02843-w · Cited by 3
Tang, D., Li, Q., Tacchi, C., Banchi, M., & Bocci, G. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189713
Che, Z., Dongwen, H., Lin, J., Wang, X., 冯荣锦, Che, X., & Wang, Y. (2026) · International Journal of Oncology · doi:10.3892/ijo.2026.5941
Risk factors associated with colorectal adenomas and the formulation of prediction models
Yu, H., 邱宗鈺, Sui, W., Han, S., Li, J., Lan, W., Sun, X., & Chi, Y. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1894239
Liu, X., Huang, L., Guo, Y., Mu, J., Zhu, X., Liu, Z., & Fu, R. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1960550
Metadata
- Authors
- Kasprzak, A.
- Affiliations
- Poznan University of Medical Sciences (PL)
- Corresponding author
- Kasprzak, Aldona
- ORCID
- Kasprzak, Aldona
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-16
- Volume
- 22
- Issue
- 12
- Pages
- 6434
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8234711
- OpenAlex
- W3169775278
- Cited by
- 248
- References
- 284
- Citations by year
- 2026: 51 · 2025: 73 · 2024: 60 · 2023: 32 · 2022: 22 · 2021: 10
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- insulin-like growth factor I, colorectal cancer, glucose metabolism, Warburg effect, aerobic glycolysis, metabolic syndrome, hyperglycemia, PI3K/AKT/mTOR pathway, glucose transporters, GLUT1, glycolytic enzymes, c-Myc, KRAS, HIF-1, TGF-β1, colorectal carcinogenesis
- MeSH terms
- Animals, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Disease Susceptibility, Glucose, Humans, Insulin-Like Growth Factor I, Metabolic Diseases, Risk Factors, Colorectal Neoplasms, Signal Transduction, Biomarkers, Gene Expression Regulation, Neoplastic, Carbohydrate Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.